Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2016 Q1 - 2018 Q1
2016^ 2017^ 2018^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 286 274 271 265 263 257 270 253 234
20 - 44 3,757 3,564 3,308 3,469 3,640 3,551 3,224 3,364 3,585
45 - 64 12,812 12,013 11,274 11,719 12,690 11,793 11,165 11,617 12,190
65 - 74 9,007 8,600 7,976 8,300 8,823 8,584 8,047 8,380 9,006
75 + 7,735 7,163 6,673 6,998 7,605 7,311 6,620 7,100 7,682
Male 19,596 18,189 17,002 17,861 19,303 18,270 17,052 17,898 19,278
Female 14,001 13,425 12,500 12,890 13,718 13,226 12,274 12,816 13,419
Diabetes 15,929 14,799 13,765 14,577 15,644 14,613 13,686 14,440 15,480
Hypertension 9,356 8,855 8,405 8,768 9,398 9,086 8,507 8,859 9,289
Glomerulonephritis 2,528 2,297 2,186 2,213 2,440 2,239 2,016 2,105 2,230
Cystic kidney 928 942 869 843 899 888 859 835 839
Other urologic 451 453 399 428 449 466 403 453 442
Other cause 3,333 3,298 2,983 3,044 3,122 3,163 2,857 2,932 3,008
Unknown cause 149 111 100 102 119 112 91 80 100
Missing cause 923 859 795 776 950 929 907 1,010 1,309
All 33,597 31,614 29,502 30,751 33,021 31,496 29,326 30,714 32,697

^ Data as of June 30, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2016 Q1 - 2018 Q1
2016^ 2017^ 2018^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 7,688 7,694 7,684 7,628 7,623 7,604 7,580 7,574 7,525
20 - 44 106,419 106,634 106,442 106,453 106,681 107,131 106,928 106,872 107,191
45 - 64 313,466 315,636 317,032 318,258 320,223 321,966 322,701 323,561 324,622
65 - 74 170,559 173,412 175,530 177,692 179,212 181,562 183,929 185,505 186,920
75 + 115,674 116,976 118,344 119,204 120,002 121,508 123,089 124,322 125,181
Male 412,830 416,658 419,499 422,185 425,086 429,029 432,038 434,379 436,896
Female 300,905 303,624 305,463 306,980 308,588 310,675 312,123 313,390 314,480
Unknown 71 70 70 70 67 67 66 65 63
Diabetes 273,974 276,968 279,019 280,816 282,845 285,380 287,115 288,431 289,626
Hypertension 182,920 184,796 186,387 187,828 189,134 190,969 192,506 193,755 194,937
Glomerulonephritis 113,854 114,302 114,640 114,918 115,281 115,673 115,844 116,085 116,357
Cystic kidney 33,966 34,448 34,850 35,240 35,606 36,002 36,407 36,740 37,040
Other urologic 11,617 11,745 11,811 11,912 11,984 12,098 12,160 12,258 12,326
Other cause 61,972 62,672 63,007 63,358 63,667 64,330 64,725 64,978 65,157
Unknown cause 23,674 23,246 22,813 22,353 21,932 21,548 21,196 20,808 20,433
Missing cause 11,829 12,175 12,505 12,810 13,292 13,771 14,274 14,779 15,563
All 713,806 720,352 725,032 729,235 733,741 739,771 744,227 747,834 751,439

^ Data as of June 30, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2016 Q1 - 2018 Q1
2016^ 2017^ 2018^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
White 22,123 20,730 19,450 20,383 21,413 20,747 19,118 20,051 21,349
Black/African American 8,510 8,101 7,400 7,681 8,503 7,794 7,430 7,675 7,985
Native American/Alaska Native 306 325 292 287 325 290 263 303 296
Asian 1,424 1,297 1,219 1,297 1,454 1,353 1,265 1,297 1,380
Pacific Islander 419 406 395 361 396 394 350 386 407
Other/Unknown * * . * . * * * *
No ME Form 899 837 787 771 940 921 904 995 1,274
Hispanic 4,923 4,387 4,009 4,245 4,507 4,393 4,111 4,276 4,668
Non-Hispanic 27,859 26,473 24,746 25,764 27,584 26,186 24,315 25,438 26,753
Unknown * * * * . * * * *
No ME Form 899 837 787 771 940 921 904 995 1,274
Hemodialysis (%)1 90.31 89.81 89.16 90.26 90.25 89.25 88.95 89.31 89.18
CAPD (%)1 4.66 4.74 5.01 4.41 4.27 4.84 4.89 4.67 4.45
CCPD (%)1 5.02 5.43 5.81 5.3 5.46 5.9 6.15 6.01 6.36
Other (%)1 0.0093 0.023 0.018 0.024 0.013 0.0033 0.014 0.01 0.013
Unknown (%)1 . . . . . 0.0067 . . .
Cathether Only (%)2 62.62 62.21 61.81 63.24 63 62.49 63.25 65.01 64.92
Catheter w/ maturing AVF (%)2 16.08 16.6 15.84 15.73 15.61 15.57 14.9 14.63 14.45
Catheter w/ maturing AVG (%)2 1.6 1.64 1.6 1.6 1.6 1.49 1.4 1.36 1.56
AVF (%)2 16.64 16.33 17.19 16.5 16.6 17.12 17.19 15.82 15.95
AVG (%)2 2.87 3.08 3.37 2.8 3.05 3.17 3.07 3.03 2.99
Other(%)2 0.15 0.085 0.18 0.12 0.13 0.15 0.18 0.12 0.091
Unknown(%)2 0.031 0.052 0.012 0.0075 0.014 0.015 0.02 0.031 0.051
Pre-ESRD EPO(% Yes)3 19.87 19.89 20.11 20.28 20.01 21.2 21.16 21.08 21.58
Pre-ESRD Nephrology(% Yes)3 74.57 75.51 76.23 75.84 76.38 78.02 78.45 77.16 78.54
Mean Serum Albumin(g/dL)4 3.15 3.18 3.21 3.17 3.16 3.21 3.23 3.21 3.2
Mean Serum Creatinine(mg/dL)4 6.4 6.37 6.42 6.42 6.41 6.38 6.37 6.41 6.41
Mean Hemoglobin(g/dL)4 9.33 9.35 9.38 9.3 9.31 9.35 9.39 9.33 9.32
All 33,683 31,700 29,543 30,781 33,031 31,501 29,331 30,715 32,699
All with ME Form 32,784 30,863 28,756 30,010 32,091 30,580 28,427 29,720 31,425
Dialysis Pts with ME Form 32,220 30,228 28,148 29,384 31,494 29,939 27,790 29,044 30,807
Hemodialysis Pts w/ ME Form 29,098 27,147 25,098 26,523 28,423 26,721 24,718 25,940 27,473

^ Data as of June 30, 2018.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.